Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

387
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
387
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

44
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
44
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56
Correlation and Regression00:53

Correlation and Regression

1.2K
In statistics, correlation describes the degree of association between two variables. In the subfield of linear regression, correlation is mathematically expressed by the correlation coefficient, which describes the strength and direction of the relationship between two variables. The coefficient is symbolically represented by 'r' and ranges from -1 to +1. A positive value indicates a positive correlation where the two variables move in the same direction. A negative value suggests a...
1.2K
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

93
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
93

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-trajectory patterns of ADL, cognition, and depression with fall risk: evidence from a longitudinal study in China.

BMC geriatrics·2026
Same author

Antibody-drug conjugates in breast cancer: from mechanism to revolutionizing clinical practice.

Molecular cancer·2026
Same author

Food environment and cardiovascular kidney metabolic diseases mortality.

NPJ science of food·2026
Same author

Letter regarding "Survival outcomes and prognostic nomogram for primary pulmonary MALT lymphoma and diffuse large B-cell lymphoma: A SEER database study".

Biomolecules & biomedicine·2026
Same author

Correlation of thalamic functional organization disturbances and genetic architecture in motor subtypes of Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Epidemiological characteristics and transmission dynamics of COVID-19 outbreaks in China: a four-year retrospective analysis using extended SEIR models.

BMC public health·2026
Same journal

PLIN1 restoration modulates lipid reprogramming and impedes tumor growth in ovarian cancer.

BMC cancer·2026
Same journal

Sex- and age- specific lung cancer incidence and mortality among Medicaid beneficiaries with and without HIV, 2001-2015.

BMC cancer·2026
Same journal

Comparative contributions of visceral adiposity and muscle-related parameters to postoperative complications after gastrectomy: a domain-based analysis.

BMC cancer·2026
Same journal

Drug-eluting bead TACE improves the efficacy of HAIC combined with molecular-targeted therapy and anti-PD-1 immunotherapy in large hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus: a multicenter retrospective cohort study.

BMC cancer·2026
Same journal

Comparative efficacy and safety of first-line immunotherapy- and targeted therapy-based regimens for advanced gastric and gastroesophageal junction cancer: a network meta-analysis.

BMC cancer·2026
Same journal

The impact of orthogonal image-guided frequency on positioning error correction and dose in postoperative radiotherapy for breast cancer.

BMC cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K

A multi-view prognostic model for diffuse large B-cell lymphoma based on kernel canonical correlation analysis and

Yanhong Luo1,2, Yongao Li3, Zhenhuan Yang3

  • 1Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China. sxmulyh@163.com.

BMC Cancer
|December 5, 2024
PubMed
Summary
This summary is machine-generated.

A novel multi-view learning (MVL) model integrating clinical and imaging data accurately predicts diffuse large B-cell lymphoma (DLBCL) patient prognosis. This approach, SVM-2K, significantly improves upon single-view models for better clinical decision-making.

Keywords:
Diffuse large B-cell lymphomaDisease prognosisKernel canonical correlation analysisMulti-view learningSupport vector machine

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.1K

Related Experiment Videos

Last Updated: Jun 5, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.1K

Area of Science:

  • Artificial Intelligence in Oncology
  • Medical Imaging Analysis
  • Machine Learning for Prognostics

Background:

  • Positron emission tomography/computed tomography (PET/CT) is the standard for diffuse large B-cell lymphoma (DLBCL) staging.
  • Existing prognostic models often overlook quantitative imaging features from PET/CT scans.
  • Integrating clinical and imaging data can enhance prognostic accuracy for DLBCL patients.

Purpose of the Study:

  • To develop a multi-view learning (MVL) model utilizing both clinical and imaging data for DLBCL prognosis prediction.
  • To improve decision-making for clinicians by providing more accurate patient prognoses.
  • To compare the performance of the proposed MVL model against single-view learning models and other MVL approaches.

Main Methods:

  • Feature engineering involved extraction, recursive feature elimination, and principal component analysis on clinical and imaging data.
  • A Support Vector Machine (SVM) model (SVM-2K) was developed using kernel canonical correlation analysis (KCCA) on mapped clinical and imaging features.
  • Model performance was evaluated using accuracy, sensitivity, F1 score, AUC, and G-mean on a test dataset.

Main Results:

  • The SVM-2K model achieved superior performance with AUC of 92.1%, accuracy of 96.9%, sensitivity of 90.9%, F1 score of 92.8%, and G-mean of 91.4%.
  • All MVL models demonstrated better performance than the best single-view learning model.
  • Feature engineering significantly improved the performance of the SVM model on DLBCL test data.

Conclusions:

  • Multi-view learning models significantly outperform single-view learning models in predicting DLBCL patient prognosis.
  • The proposed SVM-2K model demonstrates excellent performance and accuracy in prognostic prediction.
  • This MVL approach offers a valuable tool for assisting clinical decision-making in DLBCL management.